Literature DB >> 30617160

A Feedback Loop between MicroRNA 155 (miR-155), Programmed Cell Death 4, and Activation Protein 1 Modulates the Expression of miR-155 and Tumorigenesis in Tongue Cancer.

Shabir Zargar1, Vivek Tomar2, Vidyarani Shyamsundar3, Ramshankar Vijayalakshmi4, Kumaravel Somasundaram2, Devarajan Karunagaran5.   

Abstract

MicroRNA 155 (miR-155) is an oncomir, generated as a noncoding RNA from the BIC gene whose promoter activity is mainly controlled via activation protein 1 (AP-1) and NF-κB transcription factors. We found that the expression levels of miR-155 and programmed cell death 4 (Pdcd4) exhibit inverse relationships in tongue cancer cells (SAS and AWL) and tumor tissues compared to their relationships in normal FBM cells and normal tongue tissues, respectively. In silico and in vitro studies with the 3' untranslated region (UTR) of Pdcd4 via luciferase reporter assays, quantitative PCR (qPCR), and Western blotting showed that miR-155 directly targets Pdcd4 mRNA and blocks its expression. Ectopic expression of Pdcd4 or knockdown of miR-155 in tongue cancer cells predominantly reduces AP-1-dependent transcriptional activity of the BIC promoter and decreases miR-155 expression. In this study, we demonstrate that miR-155 expression is modulated by a feedback loop between Pdcd4, AP-1, and miR-155 which results in enhanced expression of miR-155 with a consequent progression of tongue tumorigenesis. Further, miR-155 knockdown increases apoptosis, arrests the cell cycle, regresses tumor size in xenograft nude mice, and reduces cell viability and colony formation in soft-agar and clonogenic assays. Thus, the restoration of Pdcd4 levels by the use of molecular manipulation such as using a miR-155 sponge has an essential role in the therapeutic intervention of cancers, including tongue cancer.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  AP-1; BICzzm321990; NF-κB; Pdcd4; apoptosis; miR-155; miR-155 sponge; tumor xenografts

Mesh:

Substances:

Year:  2019        PMID: 30617160      PMCID: PMC6399668          DOI: 10.1128/MCB.00410-18

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}.

Authors:  Fethi Louafi; Rocio T Martinez-Nunez; Tilman Sanchez-Elsner
Journal:  J Biol Chem       Date:  2010-10-29       Impact factor: 5.157

2.  Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma.

Authors:  Fei Gao; Pin Zhang; Chuixian Zhou; Jianfeng Li; Qun Wang; Faliang Zhu; Chunhong Ma; Wensheng Sun; Lining Zhang
Journal:  Oncol Rep       Date:  2007-01       Impact factor: 3.906

3.  Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.

Authors:  Xiaoping Zhang; Maoquan Li; Keqiang Zuo; Dan Li; Meng Ye; Lanbao Ding; Haidong Cai; Da Fu; Youben Fan; Zhongwei Lv
Journal:  J Clin Endocrinol Metab       Date:  2013-06-24       Impact factor: 5.958

4.  MicroRNA-183 inhibits apoptosis and promotes proliferation and invasion of gastric cancer cells by targeting PDCD4.

Authors:  Wei Gu; Tian Gao; Jie Shen; Ying Sun; Xiong Zheng; Ji Wang; Jin Ma; Xiao-Ying Hu; Jian Li; Mei-Jie Hu
Journal:  Int J Clin Exp Med       Date:  2014-09-15

5.  Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1).

Authors:  R Göke; P Barth; A Schmidt; B Samans; B Lankat-Buttgereit
Journal:  Am J Physiol Cell Physiol       Date:  2004-08-18       Impact factor: 4.249

Review 6.  Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy?

Authors:  Brigitte Lankat-Buttgereit; Rüdiger Göke
Journal:  Biol Cell       Date:  2003-11       Impact factor: 4.458

7.  Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.

Authors:  Meritxell Gironella; Mylène Seux; Min-Jue Xie; Carla Cano; Richard Tomasini; Julien Gommeaux; Stephane Garcia; Jonathan Nowak; Man Lung Yeung; Kuan-Teh Jeang; Amandine Chaix; Ladan Fazli; Yoshiharu Motoo; Qing Wang; Palma Rocchi; Antonio Russo; Martin Gleave; Jean-Charles Dagorn; Juan L Iovanna; Alice Carrier; Marie-Josèphe Pébusque; Nelson J Dusetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

8.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.

Authors:  I A Asangani; S A K Rasheed; D A Nikolova; J H Leupold; N H Colburn; S Post; H Allgayer
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

9.  MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc.

Authors:  Baltazar D Aguda; Yangjin Kim; Melissa G Piper-Hunter; Avner Friedman; Clay B Marsh
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-09       Impact factor: 11.205

10.  MicroRNA-96 Regulates Apoptosis by Targeting PDCD4 in Human Glioma Cells.

Authors:  Qing-Qing Ma; Jian-Ting Huang; Yun-Gang Xiong; Xiao-Yan Yang; Ran Han; Wang-Wen Zhu
Journal:  Technol Cancer Res Treat       Date:  2016-07-07
View more
  9 in total

1.  Methylation Mediated Silencing of miR-155 Suppresses the Development of Preeclampsia In Vitro and In Vivo by Targeting FOXO3.

Authors:  Xiaohua Luo; Ci Pan; Xiaopei Guo; Cunhua Gu; Yulian Huang; Jing Guo; Ying Zeng; Jinjing Yue; Shihong Cui
Journal:  Mediators Inflamm       Date:  2022-05-26       Impact factor: 4.529

2.  MiR-155 promotes colitis-associated intestinal fibrosis by targeting HBP1/Wnt/β-catenin signalling pathway.

Authors:  Nianshuang Li; Yaobin Ouyang; Xinbo Xu; Zhenxiang Yuan; Chunquan Liu; Zhenhua Zhu
Journal:  J Cell Mol Med       Date:  2021-03-26       Impact factor: 5.310

Review 3.  Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks.

Authors:  Rüdiger Hardeland
Journal:  Int J Mol Sci       Date:  2019-03-11       Impact factor: 5.923

Review 4.  Interplay Between Non-Coding RNAs and Programmed Cell Death Proteins.

Authors:  Soudeh Ghafouri-Fard; Bashdar Mahmud Hussen; Mahdi Mohaqiq; Hamed Shoorei; Aria Baniahmad; Mohammad Taheri; Elena Jamali
Journal:  Front Oncol       Date:  2022-03-23       Impact factor: 6.244

Review 5.  miRNA therapeutics in precision oncology: a natural premium to nurture.

Authors:  Chakresh Kumar Jain; Poornima Srivastava; Amit Kumar Pandey; Nisha Singh; R Suresh Kumar
Journal:  Explor Target Antitumor Ther       Date:  2022-08-31

6.  Combination of 7-O-geranylquercetin and microRNA-451 enhances antitumor effect of Adriamycin by reserving P-gp-mediated drug resistance in breast cancer.

Authors:  Yuling Chen; Xiaohong Li; Lei Shi; Pengfei Ma; Wei Wang; Nan Wu; Youlin Gan; Xu Han; Shanshan Huang; Xiaohui Kang; Shuxin Liu; Yuhong Zhen
Journal:  Aging (Albany NY)       Date:  2022-09-14       Impact factor: 5.955

Review 7.  MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas.

Authors:  Maria Gluud; Andreas Willerslev-Olsen; Lise Mette Rahbek Gjerdrum; Lise M Lindahl; Terkild B Buus; Mads Hald Andersen; Charlotte Menne Bonefeld; Thorbjorn Krejsgaard; Ivan V Litvinov; Lars Iversen; Jürgen C Becker; Jenny L Persson; Sergei B Koralov; Thomas Litman; Carsten Geisler; Anders Woetmann; Niels Odum
Journal:  Cancers (Basel)       Date:  2020-05-13       Impact factor: 6.639

Review 8.  From Endogenous to Synthetic microRNA-Mediated Regulatory Circuits: An Overview.

Authors:  Elsi Ferro; Chiara Enrico Bena; Silvia Grigolon; Carla Bosia
Journal:  Cells       Date:  2019-11-29       Impact factor: 6.600

9.  Proliferation and Apoptosis of B-Cell Lymphoma Cells under Targeted Regulation of FOXO3 by miR-155.

Authors:  Xiaoqiang Zheng; Hongbing Rui; Ying Liu; Jinfeng Dong
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-11-01       Impact factor: 2.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.